AmerisourceBergen Board Elects James R. Mellor Chairman, Edward E. Hagenlocker and Kurt J. Hilzinger Elected Directors at Annual Meeting of Stockholders
PHILADELPHIA--(BUSINESS WIRE)--March 5, 2004--
Robert E. Martini, Chairman, and Francis G. Rodgers, a Director, Retire at Stockholders' Meeting
Following the AmerisourceBergen Corporation (NYSE:ABC) annual meeting of stockholders, held today in Philadelphia, the Company's Board of Directors elected James R. Mellor, Chairman of the Board, replacing Robert E. Martini, who, along with Director Francis G. Rodgers, retired at the meeting.
During the annual meeting, stockholders elected Edward E. Hagenlocker and Kurt J. Hilzinger to the Company's Board of Directors. At the meeting stockholders also heard a report from out-going Chairman Martini on the Board's governance activity during the year, and Chief Executive Officer R. David Yost delivered an update on the Company's activities and outlook.
Mr. Mellor, 73, joined the AmerisourceBergen Board of Directors at the Company's inception in August 2001, having served 22 years on the Bergen Brunswig Corporation Board of Directors. He has been Chairman of USEC Inc. since 1998, and was Chairman and Chief Executive Officer of General Dynamics Corporation from 1993 to 1997. Mr. Mellor is also a director of Computer Sciences Corporation, Net2Phone, Inc., and USEC Inc.
A leader in the pharmaceutical distribution industry, Mr. Martini retired as Chairman and a member of the Board of Directors after more than four decades of combined service on the Company's and predecessor company Bergen Brunswig Corporation's boards of directors. He served as Chairman of the Board of Directors at both companies for a combined period of more than 10 years. At Bergen Brunswig, he also served as Chief Executive Officer from 1990 to 1997 and again from 1999 until the creation of AmerisourceBergen, and he served as President for more than 10 years.
Mr. Rodgers retired after more than 20 years of combined service as a member of the boards of directors of AmerisourceBergen and Bergen Brunswig. He is an author and lecturer who previously served as Vice President of Marketing at IBM Corporation.
Mr. Hagenlocker, 64, has been a member of the Board of Directors since AmerisourceBergen's inception almost three years ago, having previously served on the AmeriSource Health Corporation Board of Directors since 1999. He was Vice Chairman of Ford Motor Company from 1996 until his retirement in 1999 and held other key management positions at Ford. He is also a director of Boise Cascade Corporation, Air Products and Chemicals, Inc., American Standard Companies, Inc. and Lucent Technologies, Inc.
Mr. Hilzinger, 43, was elected to the Board of Directors for the first time and is currently President and Chief Operating Officer of AmerisourceBergen. He previously held the same position at AmeriSource Health Corporation. He joined AmeriSource in 1991 and held several other executive management positions, including Chief Financial Officer. He is also a director of Humana Inc.
The AmerisourceBergen Board of Directors is composed of nine directors.
AmerisourceBergen (NYSE:ABC) is the largest pharmaceutical services company in the United States dedicated solely to the pharmaceutical supply chain. It is the leading distributor of pharmaceutical products and services to the hospital market, physician's offices, alternate care and mail order facilities, and independent and chain pharmacies. The Company is also a leader in the long term care pharmacy marketplace, the workers' compensation fulfillment business and contract packaging for manufacturers. With more than $45 billion in annualized operating revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs more than 14,000 people. AmerisourceBergen is ranked #24 on the Fortune 500 list and was ranked #6 in the 2003 Business Week 50, a list of the 50 best performing companies in the S & P 500. For more information, go to www.amerisourcebergen.com.
This news release may contain certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained in the forward-looking statements. Forward-looking statements may include statements addressing future financial and operating results of AmerisourceBergen and the benefits and other aspects of the 2001 merger between AmeriSource Health Corporation and Bergen Brunswig Corporation.
The following factors, among others, could cause actual results to differ materially from those described in any forward-looking statements: competitive pressures; the loss of one or more key customer relationships; customer insolvencies; changes in customer mix; changes in pharmaceutical manufacturers' pricing and distribution policies; regulatory changes; changes in U.S. government policies; failure to integrate the businesses of AmeriSource and Bergen Brunswig successfully; failure to obtain and retain expected synergies from the merger of AmeriSource and Bergen Brunswig; and other economic, business, competitive, regulatory and/or operational factors affecting the business of AmerisourceBergen generally.
More detailed information about these factors is set forth in AmerisourceBergen's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for fiscal 2003.
AmerisourceBergen is under no obligation to (and expressly disclaims any such obligation to) update or alter any forward looking statements whether as a result of new information, future events or otherwise.
CONTACT: AmerisourceBergen Corporation Michael N. Kilpatric, 610-727-7118 email@example.com SOURCE: AmerisourceBergen Corporation